Following the Chinese guideline of diabetic retinopathy in our practice_Chinese Journal of Ocular Fundus Diseases

Authors：

 LiXiaoxin

People's Eye Center of People's Hospital, Peking University, Beijing 100044, China;

Corresponding author：

LiXiaoxin, Email: dr-lixiaoxin@163.com

Keywords：

Diabetic retinopathy/diagnosis; Diabetic retinopathy/therapy; Guidebooks; Editorial

DOI：

10.3760/cma.j.issn.1005-1015.2015.02.002

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Chinese Guideline of Diabetic Retinopathy was developed by the Chinese Ocular Fundus Society and Chinese Ophthalmological Society. It is the first prevention and intervention guideline document of diabetic retinopathy (DR) in China. Clinical pathways and strategies are clearly identified and described in this document for DR screening, referral, intervention, systematic management and patient education. The new DR stage classification combines the first Chinese DR classification since 1985 and the updated international classification of DR. This guideline is based on Chinese health care system, but also reflects the tradition and innovation, and reaches international practice standard. Learning and practice the guideline will promote the prevention and reduce the occurrence and development of DR in China.

Citation： LiXiaoxin. Following the Chinese guideline of diabetic retinopathy in our practice. Chinese Journal of Ocular Fundus Diseases, 2015, 31(2): 117-120. doi: 10.3760/cma.j.issn.1005-1015.2015.02.002 Copy

1.	Wild S, Roglic G, Green A, et al. Global prevalence of diabetes:estimates for the year 2000 and projections for 2030[J]. Diabetes Care, 2004, 27(5):1047-1053.
2.	National Institute for Health and Care Excellence. Quality standard for chronic heart failure..http://www.nice.org.uk/media/D6F/93/CHFQualityStandard.pdf..
3.	Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362(12):1090-1101.
4.	Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy.Ⅱ. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years[J]. Arch Ophthalmol, 1984, 102(4):520-526.
5.	Raman V, Campbell F, Holland P, et al. Retinopathy screening in children and adolescents with diabetes[J]. Ann N Y Acad Sci, 2002, 958:387-389.
6.	Goldstein DE, Blinder KJ, Ide CH, et al. Glycemic control and development of retinopathy in youth-onset insulin-dependent diabetes mellitus:results of a 12-year longitudinal study[J]. Ophthalmology, 1993, 100(8):1125-1131.
7.	Chew EY, Ambrosius WT, Davis MD, et al. Effects of medical therapies on retinopathy progression in type 2 diabetes[J]. N Engl J Med, 2010, 363(3):233-244.
8.	ADVANCE Collaborative Group.ADVANCE——Action in Diabetes and Vascular Disease:patient recruitment and characteristics of the study population at baseline[J]. Diabet Med, 2005, 22(7):882-888.
9.	Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes[J]. N Engl J Med, 2009, 360(2):129-139.
10.	Merante D, Menchini F, Truitt KE, et al. Diabetic macular edema:correlations with available diabetes therapies——evidence across a qualitative review of published literature from MEDLINE and EMBASE[J]. Drug Saf, 2010, 33(8):643-652.
11.	Penno G, Chaturvedi N, Talmud PJ, et al. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients:findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM[J]. Diabetes, 1998, 47(9):1507-1511.
12.	Chaturvedi N, Porta M, Klein R, et al. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes:randomised, placebo-controlled trials[J]. Lancet, 2008, 372(9647):1394-1402.
13.	Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema:early treatment diabetic study report number 1[J]. Arch Ophthalmol, 1985, 103(12):1796-1806.
14.	Early Treatment Diabetic Retinopathy Study Research Group. Treament techniques and clinical guidelines for photocoagulation of diabetic macular edema:early treatment diabetic study report number 2[J]. Ophthalmology, 1987, 94(7):761-774.
15.	Early Treatment Diabetic Retinopathy Study Research Group. Techniques for scatter and local photocoagulation treatment of diabetic retinopathy:early treatment diabetic study report number 3[J]. Int Ophthalmol Clin, 1987, 27(4):254-264.
16.	Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema:early treatment diabetic^® etinopathy study report number 4[J]. Int phthalmol Clin, 1987, 27(4):265-272.
17.	Early Treatment Diabetic Retinopathy Study Research Group. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics:ETDRS report number 7[J]. Ophthalmology, 1991, 98(Suppl 5):741-756.
18.	Early Treatment Diabetic Retinopathy Study Research Group. Effects of aspirin treatment on diabetic retinopathy:ETDRS report number 8[J]. Ophthalmology, 1991, 98(Suppl 5):757-765.
19.	Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9[J]. Ophthalmology, 1991, 98(Suppl 5):766-785.
20.	Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy:ETDRS report number 12[J].Ophthalmology, 1991, 98(Suppl 5):823-833.
21.	Diabetic Retinopathy Clinical Research Network.A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema[J].Ophthalmology, 2008, 115(9):1447-1459.
22.	Ishibashi T, Li XX, Koh A, et al. Ranibizumab monotherapy or combined with laser versus laser monotherapy in Asian patients with diabetic macular edema[J]. Ophthalmology, 2015, In press.
23.	Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The RESTORE Study:ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema[J].Ophthalmology, 2011, 118(4):615-625.
24.	李明武, 黎晓新, 姜燕荣, 等.晶状体手术对增生型糖尿病视网膜病变患者玻璃体切割术后虹膜新生血管形成的影响[J].眼科研究, 2000, 18(1):60-62.
25.	Greenberg PB, Tseng VL, Wu WC, et al. Prevalence and predictors of ocular complications associated with cataract surgery in United States veterans[J]. Ophthalmology, 2011, 118(3):507-514.
26.	Mittra RA, Borrillo JL, Dev S, et al. Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus[J]. Arch Ophthalmol, 2000, 118(7):912-917.
27.	Hong T, Mitchell P, de Loryn T, et al. Development and progression of diabetic retinopathy 12 months after phacoemulsification cataract surgery[J]. Ophthalmology, 2009, 116(8):1510-1514.
28.	Chung J, Kim MY, Kim HS, et al. Effect of cataract surgery on the progression of diabetic retinopathy[J]. J Cataract Refract Surg, 2002, 28(4):626-630.

1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes:estimates for the year 2000 and projections for 2030[J]. Diabetes Care, 2004, 27(5):1047-1053.
2. National Institute for Health and Care Excellence. Quality standard for chronic heart failure..http://www.nice.org.uk/media/D6F/93/CHFQualityStandard.pdf..
3. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362(12):1090-1101.
4. Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy.Ⅱ. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years[J]. Arch Ophthalmol, 1984, 102(4):520-526.
5. Raman V, Campbell F, Holland P, et al. Retinopathy screening in children and adolescents with diabetes[J]. Ann N Y Acad Sci, 2002, 958:387-389.
6. Goldstein DE, Blinder KJ, Ide CH, et al. Glycemic control and development of retinopathy in youth-onset insulin-dependent diabetes mellitus:results of a 12-year longitudinal study[J]. Ophthalmology, 1993, 100(8):1125-1131.
7. Chew EY, Ambrosius WT, Davis MD, et al. Effects of medical therapies on retinopathy progression in type 2 diabetes[J]. N Engl J Med, 2010, 363(3):233-244.
8. ADVANCE Collaborative Group.ADVANCE——Action in Diabetes and Vascular Disease:patient recruitment and characteristics of the study population at baseline[J]. Diabet Med, 2005, 22(7):882-888.
9. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes[J]. N Engl J Med, 2009, 360(2):129-139.
10. Merante D, Menchini F, Truitt KE, et al. Diabetic macular edema:correlations with available diabetes therapies——evidence across a qualitative review of published literature from MEDLINE and EMBASE[J]. Drug Saf, 2010, 33(8):643-652.
11. Penno G, Chaturvedi N, Talmud PJ, et al. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients:findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM[J]. Diabetes, 1998, 47(9):1507-1511.
12. Chaturvedi N, Porta M, Klein R, et al. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes:randomised, placebo-controlled trials[J]. Lancet, 2008, 372(9647):1394-1402.
13. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema:early treatment diabetic study report number 1[J]. Arch Ophthalmol, 1985, 103(12):1796-1806.
14. Early Treatment Diabetic Retinopathy Study Research Group. Treament techniques and clinical guidelines for photocoagulation of diabetic macular edema:early treatment diabetic study report number 2[J]. Ophthalmology, 1987, 94(7):761-774.
15. Early Treatment Diabetic Retinopathy Study Research Group. Techniques for scatter and local photocoagulation treatment of diabetic retinopathy:early treatment diabetic study report number 3[J]. Int Ophthalmol Clin, 1987, 27(4):254-264.
16. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema:early treatment diabetic^® etinopathy study report number 4[J]. Int phthalmol Clin, 1987, 27(4):265-272.
17. Early Treatment Diabetic Retinopathy Study Research Group. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics:ETDRS report number 7[J]. Ophthalmology, 1991, 98(Suppl 5):741-756.
18. Early Treatment Diabetic Retinopathy Study Research Group. Effects of aspirin treatment on diabetic retinopathy:ETDRS report number 8[J]. Ophthalmology, 1991, 98(Suppl 5):757-765.
19. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9[J]. Ophthalmology, 1991, 98(Suppl 5):766-785.
20. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy:ETDRS report number 12[J].Ophthalmology, 1991, 98(Suppl 5):823-833.
21. Diabetic Retinopathy Clinical Research Network.A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema[J].Ophthalmology, 2008, 115(9):1447-1459.
22. Ishibashi T, Li XX, Koh A, et al. Ranibizumab monotherapy or combined with laser versus laser monotherapy in Asian patients with diabetic macular edema[J]. Ophthalmology, 2015, In press.
23. Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The RESTORE Study:ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema[J].Ophthalmology, 2011, 118(4):615-625.
24. 李明武, 黎晓新, 姜燕荣, 等.晶状体手术对增生型糖尿病视网膜病变患者玻璃体切割术后虹膜新生血管形成的影响[J].眼科研究, 2000, 18(1):60-62.
25. Greenberg PB, Tseng VL, Wu WC, et al. Prevalence and predictors of ocular complications associated with cataract surgery in United States veterans[J]. Ophthalmology, 2011, 118(3):507-514.
26. Mittra RA, Borrillo JL, Dev S, et al. Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus[J]. Arch Ophthalmol, 2000, 118(7):912-917.
27. Hong T, Mitchell P, de Loryn T, et al. Development and progression of diabetic retinopathy 12 months after phacoemulsification cataract surgery[J]. Ophthalmology, 2009, 116(8):1510-1514.
28. Chung J, Kim MY, Kim HS, et al. Effect of cataract surgery on the progression of diabetic retinopathy[J]. J Cataract Refract Surg, 2002, 28(4):626-630.

Chinese Journal of Ocular Fundus Diseases

Following the Chinese guideline of diabetic retinopathy in our practice

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content